Exclusion of BRAFV599E as a melanoma susceptibility mutation
Open Access
- 2 June 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 106 (1) , 78-80
Abstract
Very recently, BRAF mutations were found in about 2/3 of malignant melanomas and at lower frequencies in other human cancers. The BRAF gene codes for a protein in the mitogen‐activated protein kinase (MAPK) pathway. All mutations identified to date are within the kinase domain, with a single missense mutation (V599E) accounting for 80%. We investigated the hypothesis that this common somatic BRAF mutation (V599E) would contribute to melanoma predisposition in familial and polygenic malignant melanoma if occuring as a germ‐line mutation. We performed comprehensive mutational screening of exon 15 of BRAF using DHPLC (denaturing high‐performance liquid chromatography) and DNA sequencing techniques. No V599E mutation could be detected in 172 melanoma patients comprising 46 familial cases, 21 multiple melanoma patients and 106 cases with at least one first‐degree relative suffering from other cancers. We therefore conclude that the common somatic BRAF mutation V599E does not contribute to polygenic and familial melanoma predisposition.Keywords
This publication has 15 references indexed in Scilit:
- High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma FamiliesJNCI: Journal of the National Cancer Institute, 2000
- Characterization of ligurian melanoma families and risk of occurrence of other neoplasiaInternational Journal of Cancer, 1999
- CDKN2A Variants in a Population-Based Sample of Queensland Families With MelanomaJNCI: Journal of the National Cancer Institute, 1999
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998
- Germline Mutations of the CDKN2 Gene in UK Melanoma FamiliesHuman Molecular Genetics, 1997
- Screening for CDKN2A Mutations in Hereditary MelanomaJNCI: Journal of the National Cancer Institute, 1997
- Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.Proceedings of the National Academy of Sciences, 1996
- Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindredsNature Genetics, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusNature Genetics, 1994